Pomanda estimates the enterprise value of VITAL PHARMA LIMITED at £233.1k based on a Turnover of £524.2k and 0.44x industry multiple (adjusted for size and gross margin).
vital pharma limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of VITAL PHARMA LIMITED at £0 based on an EBITDA of £-6.5k and a 4.49x industry multiple (adjusted for size and gross margin).
vital pharma limitedEstimated Valuation
£101.3k
Pomanda estimates the enterprise value of VITAL PHARMA LIMITED at £101.3k based on Net Assets of £52.9k and 1.92x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Vital Pharma LimitedOverview
Vital Pharma Limited is a live company located in barnard castle, DL12 8XT with a Companies House number of 09422730. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in February 2015, it's largest shareholder is
kaleem sharif
with a 100% stake. Vital Pharma Limited is a established,
small sized company, Pomanda has estimated its turnover at
£524.2k with
healthy
growth in recent years.
Pomanda's financial health check has awarded Vital Pharma Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 7 areas for improvement. Company Health Check FAQs
Health Rating2out of 5
1 Strong
4 Regular
7 Weak
Size
annual sales of £524.2k, make it smaller than the average company (£25.2m)
£524.2k - Vital Pharma Limited
£25.2m - Industry AVG
Growth
3 year (CAGR) sales growth of 4%, show it is growing at a slower rate (5.6%)
4% - Vital Pharma Limited
5.6% - Industry AVG
Production
with a gross margin of 27.2%, this company has a comparable cost of product (27.2%)
27.2% - Vital Pharma Limited
27.2% - Industry AVG
Profitability
an operating margin of -3.9% make it less profitable than the average company (3.7%)
-3.9% - Vital Pharma Limited
3.7% - Industry AVG
Employees
with 1 employees, this is below the industry average (36)
1 - Vital Pharma Limited
36 - Industry AVG
Pay Structure
on an average salary of £77.3k, the company has an equivalent pay structure (£77.3k)
£77.3k - Vital Pharma Limited
£77.3k - Industry AVG
Efficiency
resulting in sales per employee of £524.2k, this is less efficient (£674.5k)
£524.2k - Vital Pharma Limited
£674.5k - Industry AVG
Debtor Days
it gets paid by customers after 56 days, this is near the average (59 days)
56 days - Vital Pharma Limited
59 days - Industry AVG
Creditor Days
its suppliers are paid after 44 days, this is slower than average (30 days)
44 days - Vital Pharma Limited
30 days - Industry AVG
Stock Days
it holds stock equivalent to 154 days, this is more than average (62 days)
154 days - Vital Pharma Limited
62 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 12 weeks, this is average cash available to meet short term requirements (12 weeks)
12 weeks - Vital Pharma Limited
12 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 87.2%, this is a higher level of debt than the average (53.8%)
87.2% - Vital Pharma Limited
53.8% - Industry AVG
VITAL PHARMA LIMITED financials
EXPORT
Vital Pharma Limited's latest turnover from April 2024 is estimated at £524.2 thousand and the company has net assets of £52.9 thousand. According to their latest financial statements, we estimate that Vital Pharma Limited has 1 employee and maintains cash reserves of £54.4 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Apr 2024
Apr 2023
Apr 2022
Apr 2021
Apr 2020
Apr 2019
Apr 2018
Apr 2017
Apr 2016
Turnover
524,188
546,159
477,150
460,353
321,143
2,917
335,245
160,264
164,303
Other Income Or Grants
Cost Of Sales
381,782
399,710
351,965
349,754
235,100
2,148
246,384
118,144
121,268
Gross Profit
142,405
146,448
125,184
110,599
86,043
768
88,861
42,120
43,034
Admin Expenses
163,103
115,053
134,277
-40,943
85,073
-8,358
81,819
55,133
64,545
Operating Profit
-20,698
31,395
-9,093
151,542
970
9,126
7,042
-13,013
-21,511
Interest Payable
7,451
8,929
4,436
2,703
2,991
8,806
13,231
6,249
Interest Receivable
3,056
2,574
361
20
2
302
210
18
22
Pre-Tax Profit
-25,093
25,040
-13,167
148,858
-2,019
622
-5,979
-19,244
-21,489
Tax
-6,260
-28,283
-118
Profit After Tax
-25,093
18,780
-13,167
120,575
-2,019
504
-5,979
-19,244
-21,489
Dividends Paid
Retained Profit
-25,093
18,780
-13,167
120,575
-2,019
504
-5,979
-19,244
-21,489
Employee Costs
77,325
76,006
68,553
65,531
59,696
61,339
60,825
54,215
44,077
Number Of Employees
1
1
1
1
1
1
1
1
1
EBITDA*
-6,492
45,549
4,907
154,542
970
9,126
7,042
-13,013
-21,511
* Earnings Before Interest, Tax, Depreciation and Amortisation
Apr 2024
Apr 2023
Apr 2022
Apr 2021
Apr 2020
Apr 2019
Apr 2018
Apr 2017
Apr 2016
Tangible Assets
14,669
28,875
42,000
67,000
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
14,669
28,875
42,000
67,000
Stock & work in progress
161,444
162,651
155,472
157,000
43,382
32,729
Trade Debtors
80,450
80,450
57,390
79,528
79,995
54,865
33,234
Group Debtors
Misc Debtors
102,460
100,450
85,450
20,000
25,000
8,543
52,796
106,245
Cash
54,396
62,031
59,095
37,244
2,114
2,456
78,036
6,016
8,636
misc current assets
819
total current assets
399,569
405,582
357,407
293,772
107,109
10,999
185,697
188,877
41,365
total assets
414,238
434,457
399,407
360,772
107,109
10,999
185,697
188,877
41,365
Bank overdraft
3,600
45,357
45,357
44,314
44,314
53,760
207,146
199,970
Bank loan
Trade Creditors
46,660
46,661
34,314
13,015
2,400
342
4,835
Group/Directors Accounts
140,346
94,691
190,774
1,247
other short term finances
hp & lease commitments
other current liabilities
29,008
28,031
28,025
18,094
2,163
1,857
25,262
24,804
62,853
total current liabilities
219,614
214,740
298,470
75,423
48,877
57,206
232,408
229,609
62,853
loans
41,755
41,755
41,755
hp & lease commitments
Accruals and Deferred Income
other liabilities
100,000
100,000
213,000
106,458
provisions
total long term liabilities
141,755
141,755
41,755
213,000
106,458
total liabilities
361,369
356,495
340,225
288,423
155,335
57,206
232,408
229,609
62,853
net assets
52,869
77,962
59,182
72,349
-48,226
-46,207
-46,711
-40,732
-21,488
total shareholders funds
52,869
77,962
59,182
72,349
-48,226
-46,207
-46,711
-40,732
-21,488
Apr 2024
Apr 2023
Apr 2022
Apr 2021
Apr 2020
Apr 2019
Apr 2018
Apr 2017
Apr 2016
Operating Activities
Operating Profit
-20,698
31,395
-9,093
151,542
970
9,126
7,042
-13,013
-21,511
Depreciation
14,206
14,154
14,000
3,000
Amortisation
Tax
-6,260
-28,283
-118
Stock
-1,207
7,179
-1,528
157,000
-43,382
10,653
32,729
Debtors
2,010
38,060
43,312
-5,467
96,452
-99,118
-31,818
139,479
Creditors
-1
12,347
21,299
10,615
2,058
342
-4,835
4,835
Accruals and Deferred Income
977
6
9,931
15,931
306
-23,405
458
-38,049
62,853
Deferred Taxes & Provisions
Cash flow from operations
-6,319
6,403
-5,647
1,272
-93,118
85,063
77,865
-196,359
8,613
Investing Activities
capital expenditure
-1,029
11,000
-70,000
Change in Investments
cash flow from investments
-1,029
11,000
-70,000
Financing Activities
Bank loans
Group/Directors Accounts
45,655
-96,083
190,774
-1,247
1,247
Other Short Term Loans
Long term loans
41,755
Hire Purchase and Lease Commitments
other long term liabilities
100,000
-213,000
106,542
106,458
share issue
1
interest
-4,395
-6,355
-4,075
-2,683
-2,989
-8,504
-13,021
-6,231
22
cash flow from financing
41,260
-2,438
15,454
103,859
102,222
-7,257
-13,021
-6,231
23
cash and cash equivalents
cash
-7,635
2,936
21,851
35,130
-342
-75,580
72,020
-2,620
8,636
overdraft
-41,757
1,043
-9,446
-153,386
7,176
199,970
change in cash
34,122
2,936
20,808
35,130
9,104
77,806
64,844
-202,590
8,636
vital pharma limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for vital pharma limited. Get real-time insights into vital pharma limited's credit score, group structure and payment trends.
Perform a competitor analysis for vital pharma limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in DL12 area or any other competitors across 12 key performance metrics.
vital pharma limited Ownership
VITAL PHARMA LIMITED group structure
Vital Pharma Limited has no subsidiary companies.
Ultimate parent company
VITAL PHARMA LIMITED
09422730
VITAL PHARMA LIMITED Shareholders
The sole shareholder of Vital Pharma Limited is Kaleem Sharif.
kaleem sharif
100%
vital pharma limited directors
Vital Pharma Limited currently has 1 director, Mr Kaleem Sharif serving since Sep 2019.
enterprise house, harmire enterprise park, barnard castle, DL12 8XT
Bank
-
Legal Advisor
-
vital pharma limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to vital pharma limited. Currently there are 0 open charges and 2 have been satisfied in the past.
vital pharma limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for VITAL PHARMA LIMITED. This can take several minutes, an email will notify you when this has completed.
vital pharma limitedCompanies House Filings - See Documents
